newsfilter
← Latest News
PR Newswire·

Aridis Pharmaceuticals Announces First Quarter 2021 Results

LOS GATOS, Calif., May 11, 2021 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, today reported finan